VMP 318058009

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Spironolactone 100mg tablets
BNF code 0202030S0AAAVAV
Virtual Therapeutic Moiety Spironolactone
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Spironolactone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 100.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Aldactone 100mg tablets (Pfizer Ltd)
Spironolactone 100mg tablets (A A H Pharmaceuticals Ltd)
Spironolactone 100mg tablets (Accord Healthcare Ltd)
Spironolactone 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Spironolactone 100mg tablets (Almus Pharmaceuticals Ltd)
Spironolactone 100mg tablets (Bristol Laboratories Ltd)
Spironolactone 100mg tablets (DE Pharmaceuticals)
Spironolactone 100mg tablets (Genesis Pharmaceuticals Ltd)
Spironolactone 100mg tablets (Medihealth (Northern) Ltd)
Spironolactone 100mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Spironolactone 100mg tablets 100 tablet
Spironolactone 100mg tablets 20 tablet
Spironolactone 100mg tablets 250 tablet
Spironolactone 100mg tablets 28 tablet
Spironolactone 100mg tablets 30 tablet
Spironolactone 100mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20221128000001, imported on 29th November 2022 at 03:52:52.